報價延遲最少15分鐘:2026/07/23 15:39 EDT
常規時段
|
|
|
|
|
||||||||||||
|
|
|
|
|
2.4 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-5.63/--
|
|
企業價值
6.28M
|
| 資產負債 |
|
每股賬面淨值
7.98
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
45.72K
|
|
每股收益
0.03
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
同行比較之報價最少15分鐘延遲 (夜盤時段除外)
|
業務概覽
|
|||
| Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), proprietary signal processing techniques, biomarkers, and augmented intelligence algorithms to optimize clinical treatments. The Company is first addressing the chronic low back pain market with Nociscan. Through a cloud connection, Nociscan receives magnetic resonance spectroscopy (MRS) data from an MRI machine for each lumbar disc being evaluated. In the cloud, proprietarysignal processing techniques extract and quantify chemical biomarkers demonstrated to be associated with disc pain. When used with other diagnostic tools, Nociscan provides critical insights into the location of a patient's low back pain, giving physicians clarity to optimize treatment strategies. |
